Hengan International is a leading personal care product manufacturer in China. Its business comprises tissue paper products (close to 60% of sales), sanitary napkins (26% of sales), disposable diapers (5% of sales), and others.
1998
24K+
LTM Revenue $3.4B
LTM EBITDA $569M
$2.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hengan Group has a last 12-month revenue (LTM) of $3.4B and a last 12-month EBITDA of $569M.
In the most recent fiscal year, Hengan Group achieved revenue of $2.9B and an EBITDA of $566M.
Hengan Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Hengan Group valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $3.4B | XXX | $2.9B | XXX | XXX | XXX |
Gross Profit | $1.1B | XXX | $935M | XXX | XXX | XXX |
Gross Margin | 33% | XXX | 32% | XXX | XXX | XXX |
EBITDA | $569M | XXX | $566M | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 20% | XXX | XXX | XXX |
EBIT | $456M | XXX | $342M | XXX | XXX | XXX |
EBIT Margin | 13% | XXX | 12% | XXX | XXX | XXX |
Net Profit | $343M | XXX | $293M | XXX | XXX | XXX |
Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Hengan Group's stock price is HKD 21 (or $3).
Hengan Group has current market cap of HKD 24.2B (or $3.1B), and EV of HKD 22.9B (or $2.9B).
See Hengan Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.9B | $3.1B | XXX | XXX | XXX | XXX | $0.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Hengan Group has market cap of $3.1B and EV of $2.9B.
Hengan Group's trades at 1.0x EV/Revenue multiple, and 5.2x EV/EBITDA.
Equity research analysts estimate Hengan Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hengan Group has a P/E ratio of 9.8x.
See valuation multiples for Hengan Group and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $3.1B | XXX | $3.1B | XXX | XXX | XXX |
EV (current) | $2.9B | XXX | $2.9B | XXX | XXX | XXX |
EV/Revenue | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
EV/EBITDA | 5.6x | XXX | 5.2x | XXX | XXX | XXX |
EV/EBIT | 7.0x | XXX | 8.5x | XXX | XXX | XXX |
EV/Gross Profit | 2.8x | XXX | n/a | XXX | XXX | XXX |
P/E | 9.8x | XXX | 10.5x | XXX | XXX | XXX |
EV/FCF | 18.4x | XXX | 15.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHengan Group's last 12 month revenue growth is 2%
Hengan Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $25K for the same period.
Hengan Group's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hengan Group's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hengan Group and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 2% | XXX | 6% | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 20% | XXX | XXX | XXX |
EBITDA Growth | -2% | XXX | -12% | XXX | XXX | XXX |
Rule of 40 | 24% | XXX | 22% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $25K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hengan Group acquired XXX companies to date.
Last acquisition by Hengan Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Hengan Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Hengan Group founded? | Hengan Group was founded in 1998. |
Where is Hengan Group headquartered? | Hengan Group is headquartered in Hong Kong. |
How many employees does Hengan Group have? | As of today, Hengan Group has 24K+ employees. |
Who is the CEO of Hengan Group? | Hengan Group's CEO is Mr. Ching Lau Hui. |
Is Hengan Group publicy listed? | Yes, Hengan Group is a public company listed on HKG. |
What is the stock symbol of Hengan Group? | Hengan Group trades under 01044 ticker. |
When did Hengan Group go public? | Hengan Group went public in 1998. |
Who are competitors of Hengan Group? | Similar companies to Hengan Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Hengan Group? | Hengan Group's current market cap is $3.1B |
What is the current revenue of Hengan Group? | Hengan Group's last 12 months revenue is $3.4B. |
What is the current revenue growth of Hengan Group? | Hengan Group revenue growth (NTM/LTM) is 2%. |
What is the current EV/Revenue multiple of Hengan Group? | Current revenue multiple of Hengan Group is 0.9x. |
Is Hengan Group profitable? | Yes, Hengan Group is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Hengan Group? | Hengan Group's last 12 months EBITDA is $569M. |
What is Hengan Group's EBITDA margin? | Hengan Group's last 12 months EBITDA margin is 17%. |
What is the current EV/EBITDA multiple of Hengan Group? | Current EBITDA multiple of Hengan Group is 5.6x. |
What is the current FCF of Hengan Group? | Hengan Group's last 12 months FCF is $172M. |
What is Hengan Group's FCF margin? | Hengan Group's last 12 months FCF margin is 5%. |
What is the current EV/FCF multiple of Hengan Group? | Current FCF multiple of Hengan Group is 18.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.